CY Sun, J Nie, ZL Zheng, J Zhao, LM Wu, Y Zhu… - Biomedicine & …, 2019 - Elsevier
Cisplatin remains the standard first-line chemotherapeutic agent in the treatment of many
types of cancers, but its clinical application is hindered by its severe nephrotoxicity. Previous …